These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 19052481

  • 1. Lack of protection with a novel, selective melanocortin receptor subtype-4 agonist RY767 in a rat transient middle cerebral artery occlusion stroke model.
    Regan C, Shepherd C, Strack A, Weinberg D, Nargund R, Ye Z, Pollard P, Fong T, Reynolds I, Lynch J.
    Pharmacology; 2009; 83(1):38-44. PubMed ID: 19052481
    [Abstract] [Full Text] [Related]

  • 2. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia.
    Nurmi A, Miettinen TK, Puoliväli J, Pussinen R, Soleti A, Bagate K, Riccardino F, Grundy RI, Yrjänheikki J, Canistro D, Paolini M.
    Brain Res; 2008 May 01; 1207():174-81. PubMed ID: 18374313
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid.
    Khansari PS, Halliwell RF.
    Neurochem Int; 2009 Dec 01; 55(7):683-8. PubMed ID: 19563851
    [Abstract] [Full Text] [Related]

  • 8. Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat.
    Zhang Y, Feustel PJ, Kimelberg HK.
    Brain Res; 2006 Jun 13; 1094(1):200-6. PubMed ID: 16709402
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
    Liang S, Pong K, Gonzales C, Chen Y, Ling HP, Mark RJ, Boschelli F, Boschelli DH, Ye F, Barrios Sosa AC, Mansour TS, Frost P, Wood A, Pangalos MN, Zaleska MM.
    J Pharmacol Exp Ther; 2009 Dec 13; 331(3):827-35. PubMed ID: 19741150
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury.
    Mauler F, Horváth E.
    J Cereb Blood Flow Metab; 2005 Apr 13; 25(4):451-9. PubMed ID: 15674237
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotection by oxygen in acute transient focal cerebral ischemia is dose dependent and shows superiority of hyperbaric oxygenation.
    Eschenfelder CC, Krug R, Yusofi AF, Meyne JK, Herdegen T, Koch A, Zhao Y, Carl UM, Deuschl G.
    Cerebrovasc Dis; 2008 Apr 13; 25(3):193-201. PubMed ID: 18212507
    [Abstract] [Full Text] [Related]

  • 12. ARD-353 [4-((2R,5S)-4-(R)-(4-diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic acid], a novel nonpeptide delta receptor agonist, reduces myocardial infarct size without central effects.
    Watson MJ, Holt JD, O'Neill SJ, Wei K, Pendergast W, Gross GJ, Gengo PJ, Chang KJ.
    J Pharmacol Exp Ther; 2006 Jan 13; 316(1):423-30. PubMed ID: 16188952
    [Abstract] [Full Text] [Related]

  • 13. Effect of aminoguanidine on post-ischemic damage in rodent model of stroke.
    Vakili A, Zahedi-Khorasani M.
    Pak J Pharm Sci; 2008 Jan 13; 21(1):24-8. PubMed ID: 18166515
    [Abstract] [Full Text] [Related]

  • 14. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M, Moloudi R, Arababadi MK, Shamsizadeh A, Javanmardi K.
    Brain Res; 2009 May 19; 1271():121-7. PubMed ID: 19332033
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats.
    Sehara Y, Hayashi T, Deguchi K, Zhang H, Tsuchiya A, Yamashita T, Lukic V, Nagai M, Kamiya T, Abe K.
    J Neurosci Res; 2007 Aug 01; 85(10):2167-74. PubMed ID: 17497673
    [Abstract] [Full Text] [Related]

  • 18. Selective MMP-inhibition with Ro 28-2653 in acute experimental stroke--a magnetic resonance imaging efficacy study.
    Nagel S, Heinemann PV, Heiland S, Koziol J, Gardner H, Wagner S.
    Brain Res; 2011 Jan 12; 1368():264-70. PubMed ID: 20971083
    [Abstract] [Full Text] [Related]

  • 19. Experimental stroke: ischaemic lesion volume and oedema formation differ among rat strains (a comparison between Wistar and Sprague-Dawley rats using MRI).
    Walberer M, Stolz E, Müller C, Friedrich C, Rottger C, Blaes F, Kaps M, Fisher M, Bachmann G, Gerriets T.
    Lab Anim; 2006 Jan 12; 40(1):1-8. PubMed ID: 16460584
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.